Observational studyJournal of nephrology2023

Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project.

Jim Alkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.